EIR Regeneron Pharmaceuticals Jun 2014

Robert Horan FDA$595.00 - Available Now

FDA investigators audited the Regeneron Pharmaceuticals - Rensselaer, NY, United States facility and issued inspectional observation (via FDA 483) on 13 Jun 2014.

Product details

  • Category:
  • Inspection end: 13 Jun 2014
  • Location: Rensselaer, United States
  • FEI: 1000514603
Add To Cart